Home » Newsletters » BioWorld Science

BioWorld Science

July 10, 1997

View Archived Issues

N-type calcium channel blockers isolated from marine bacterium

Korean researchers discover new melanin synthesis inhibitors

Lepetit discovers IL-1RI inhibitors from microbial samples

Effect of aripiprazole on dopaminergic transmission in striatal neurons

Kyowa Hakko develops cell adhesion inhibitors

New lactam compounds for sepsis and RA

Lupulon for the treatment of MRSA

Kanebo describes new selectin inhibitors

Potential role for melatonin in epilepsy therapy?

Free radical-scavenging activity described for zonisamide

Lamotrigine shows favorable psychotropic effects in epileptics

Adverse CNS effects reported for antiepileptic drug

UCSF scientist complains of regressive tendency in epilepsy therapy

Novel hemoregulatory compounds from SKB

Selective alpha1a-adrenoceptor blockers described by Merck & Co.

Sanwa Kagaku discloses novel selectin inhibitors for inflammatory disorders

Preclinical data reported for JTP-2942

Yamanouchi, Ferring collaborate on endothelin antagonists

MS-818 effective in rat model of nerve degeneration

Clinical evaluation of FO-726

Novel approach to epilepsy treatment recommended for approval by FDA panel

CPC-111 moves toward pivotal trials for bypass surgery

Further phase II results for Ceresine in head injury

Exocell presents humanized MAb for diabetic nephropathy

Preclinical and clinical antidepressant properties of tolcapone

Nefazodone evaluated for social phobia

New clinical uses of risperidone investigated

Role of glutamate antagonists in epilepsy debated

Hycamtin launched in Canada

FDA clears Bayer's cholesterol-lowering agent

Smoking cessation treatment launched in the U.S.

Future concepts in pain

SNX-111 and SNX-230, analgesic conopeptides and calcium channel blockers

Management of peripheral pain using neurotrophins

NK1 receptor antagonists for pain

c-fos gene is implicated in pain states

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...